Lipid-based nanocarriers have established themselves as a cornerstone of modern drug delivery, offering a versatile platform for the encapsulation of diverse therapeutic payloads. Their utility spans from small hydrophobic and hydrophilic molecules to complex, high-molecular-weight biologics, such as proteins and nucleic acids. Although many manufacturing approaches are available, their effectiveness, scalability, and control over particle size distribution can vary widely according to the preparation strategy and process conditions. This study systematically compared bench-scale thin-film hydration (TFH) followed by extrusion with scalable microfluidic mixing, and Impingement Jets Mixing (IJM), under standardized conditions. Liposomes composed of phosphatidylcholine S100 and cholesterol (3:1 mass ratio; final total lipid concentration of 10 mg/mL) were prepared using either Milli-Q water or phosphate-buffered saline (PBS, pH 7.4) as the aqueous phase, targeting particle sizes of approximately 100 and 200 nm. The resulting formulations were characterized in terms of size, polydispersity, ζ-potential, colloidal stability, particle concentration and phospholipid recovery. All manufacturing approaches generated liposomes within the targeted nanoscale ranges. For formulations targeting 100 nm, hydrodynamic diameters ranged approximately 90-125 nm in H2O and 75-130 nm in PBS, whereas formulations targeting 200 nm exhibited diameters of approximately 170-195 nm in H2O and 145-200 nm in PBS. Formulations targeting 100 nm generally exhibited greater colloidal stability and lower polydispersity than their 200 nm counterparts, while particle concentration varied markedly among manufacturing methods. Despite these differences, phospholipid recovery remained relatively high (approximately 55% to 95% in H2O and from 55% to nearly 100% in PBS). Integrated NTA and phospholipid analyses revealed strong inverse correlations between particle concentration and estimated phospholipid content per particle in both H2O (Spearman r = -0.811, p = 0.0007) and PBS (r = -0.902, p < 0.0001). Overall, these findings demonstrate that liposome manufacturing technology should be considered a critical formulation and process-design parameter, as the selection of an appropriate production strategy requires the simultaneous consideration of product quality, material recovery, reproducibility, and scalability.

From laboratory to scalable manufacturing: Comparative analysis of thin film hydration, microfluidics, and impingement jets mixing

Azzurra Saudelli;Marco Carnaroli;Vildan Demirtas;Annalisa Aluigi;Mattia Tiboni
;
Luca Casettari
2027

Abstract

Lipid-based nanocarriers have established themselves as a cornerstone of modern drug delivery, offering a versatile platform for the encapsulation of diverse therapeutic payloads. Their utility spans from small hydrophobic and hydrophilic molecules to complex, high-molecular-weight biologics, such as proteins and nucleic acids. Although many manufacturing approaches are available, their effectiveness, scalability, and control over particle size distribution can vary widely according to the preparation strategy and process conditions. This study systematically compared bench-scale thin-film hydration (TFH) followed by extrusion with scalable microfluidic mixing, and Impingement Jets Mixing (IJM), under standardized conditions. Liposomes composed of phosphatidylcholine S100 and cholesterol (3:1 mass ratio; final total lipid concentration of 10 mg/mL) were prepared using either Milli-Q water or phosphate-buffered saline (PBS, pH 7.4) as the aqueous phase, targeting particle sizes of approximately 100 and 200 nm. The resulting formulations were characterized in terms of size, polydispersity, ζ-potential, colloidal stability, particle concentration and phospholipid recovery. All manufacturing approaches generated liposomes within the targeted nanoscale ranges. For formulations targeting 100 nm, hydrodynamic diameters ranged approximately 90-125 nm in H2O and 75-130 nm in PBS, whereas formulations targeting 200 nm exhibited diameters of approximately 170-195 nm in H2O and 145-200 nm in PBS. Formulations targeting 100 nm generally exhibited greater colloidal stability and lower polydispersity than their 200 nm counterparts, while particle concentration varied markedly among manufacturing methods. Despite these differences, phospholipid recovery remained relatively high (approximately 55% to 95% in H2O and from 55% to nearly 100% in PBS). Integrated NTA and phospholipid analyses revealed strong inverse correlations between particle concentration and estimated phospholipid content per particle in both H2O (Spearman r = -0.811, p = 0.0007) and PBS (r = -0.902, p < 0.0001). Overall, these findings demonstrate that liposome manufacturing technology should be considered a critical formulation and process-design parameter, as the selection of an appropriate production strategy requires the simultaneous consideration of product quality, material recovery, reproducibility, and scalability.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11576/2784973
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact